Arabic Arabic English English French French German German
dark

Discovery offers insight for development of cancer therapies targeting mutant p53

The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Insurer dispute complicates Boy Scouts abuse claims payout

Next Post

High virus count in the lungs drives COVID-19 deaths

Related Posts
Total
0
Share